Journal profile · ETHICS
New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body
ISSN 2050-2877 · eISSN 2050-2885 · Taylor & Francis
New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body: CAS Zone 3 · Philosophy (2025 upgraded edition); impact factor 0.9 (journal website); hybrid open access; APC charged, amount not published; review about 330 days (first decision after review, publisher); acceptance rate 50% (journal website); 13 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body is published by Taylor & Francis and is in Zone 3 of Philosophy in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ethics in medical practice, Reproductive Health and Technologies and Ethics and Legal Issues in Pediatric Healthcare, together about 37% of its articles. Its main subfields are Public Health, Environmental and Occupational Health. (generated from OpenAlex topic counts and CAS ranking data)
The New Bioethics seeks to reclaim bioethics as a diverse and multidisciplinary project. It provides a space for dialogue between different perspectives on biotechnology and the human body and offers the chance to find new kinds of common ground. The journal invites contributions from a range of perspectives, from STEAM, law, philosophy, social and political sciences and theology from diverse religions. The journal, whilst regularly publishing papers on longstanding ethical issues such as brain death and conscientious objection in healthcare, focuses on the interface of new advances and the human body. It covers such issues as genomic editing, regenerative medicine (including the use of stem cells), human enhancement, ectogenesis and animal-human hybrids. In addition to research papers and book reviews, The New Bioethics has an Essay section which allows authors the opportunity to explore an issue in greater depth than in papers which are limited to 7000 words. Inquiries about the suitability of papers or to discuss potential topics for the Essay section or special issues can be made to patrick.wall@taylorandfrancis.com. Peer Review Policy Submitted papers deemed to be appropriate for peer review by the Editor-in-Chief will be subjected to rigorous anonymous review by independent referees under the supervision of the Editor-in-Chief and the Managing Editor, with the help of a distinguished international advisory board. The Journal operates a double-anonymized peer review system, with a minimum of two reviews per paper. Submissions can be made through the online submission system www.edmgr.com/nbi Publishing Ethics The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of Committee of Publications Ethics (COPE) and utilises CrossCheck for all Journals. More information on our ethical standards and policies can be found here: http://authorservices.taylorandfrancis.com/ethics-for-authors/ The Journal has an appeals and complaints policy which can be viewed here: https://authorservices.taylorandfrancis.com/peer-review-appeals-and-complaints-from-authors/.
From the journal's Aims & Scope
Research area (LetPub): ETHICS
Editor-in-chief Matthew JamesPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 3, Belgium 1, Denmark 1, Malaysia 1 (6 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ethics in medical practiceHealth Professions15.6%
- Reproductive Health and TechnologiesMedicine11.7%
- Ethics and Legal Issues in Pediatric HealthcareMedicine9.7%
- Neuroethics, Human Enhancement, Biomedical InnovationsNeuroscience7.8%
- Patient Dignity and PrivacyMedicine5%
- Palliative Care and End-of-Life IssuesMedicine4.8%
- Organ Donation and TransplantationMedicine4.5%
- Ethics in Clinical ResearchMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Philosophy Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Philosophy | Zone 3 |
| Minor | Ethics | Zone 4 |
| Minor | Medical Ethics | Zone 4 |
| Minor | Social Sciences, Biomedical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Philosophy Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Philosophy | Zone 2 |
| Minor | Ethics | Zone 3 |
| Minor | Medical Ethics | Zone 3 |
| Minor | Social Sciences, Biomedical | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbasePublisher website
Other: Index Medicus, Google Scholar, EBSCO, ProQuest, Baidu, Naver, Portico, Baidu Scholar, British Library Inside, Danish Bibliometric Research Indicator (BFI), DTU Findit, EBSCO Databases, Electronic Journals Library (EZB), Finnish Publication Forum (Julkaisufoorumi), Genamics JournalSeek, Globethics.net, JournalTOCs, Naver Academic, Norwegian Register of Scientific Journals and Publishers, ProQuest Biological Science Collection, SciBase, Technical Info Centre of Denmark, DTU library, Ulrich's Periodicals Directory, Wellcome Library, Zetoc
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.2Publisher website ·
- CiteScore 2026-06
- 3.6LetPub ·
- CiteScore (publisher) 2025
- 3.6Publisher website ·
- SJR 2026-06
- 0.36LetPub ·
- SJR (publisher) 2025
- 0.36Publisher website ·
- SNIP 2026-06
- 0.57LetPub ·
- SNIP (publisher) 2025
- 0.57Publisher website ·
- h-index
- 26OpenAlex ·
- i10-index
- 87OpenAlex ·
- 2-year mean citedness
- 1.02OpenAlex ·
- Self-citation rate
- 11.1%LetPub ·
- Share of gold OA articles
- 16.67%LetPub ·
Volume
- Articles per year
- 9LetPub ·
- Downloads per year (publisher)
- 86,000Publisher website ·
- Downloads per year (publisher) 2025
- 86,000Publisher website ·
Articles by year OpenAlex count · 402 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 9 | 3 |
| 2025 | 13 | 4 | 8 |
| 2024 | 23 | 14 | 46 |
| 2023 | 22 | 8 | 37 |
| 2022 | 55 | 27 | 386 |
| 2021 | 35 | 7 | 148 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
330 daysfirst decision after review
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Acceptance rate (publisher)
- 50%Publisher website ·
- Submission to first decision
- 253 daysPublisher website ·
- Submission to first decision 2025
- 253 daysPublisher website ·
- First decision after review
- 330 daysPublisher website ·
- First decision after review 2025
- 330 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- book reviewsIn addition to research papers and book reviews, The New Bioethics has an Essay section which allows authors the opportunity to explore an issue in greater dept…Length not stated
- essayIn addition to research papers and book reviews, The New Bioethics has an Essay section which allows authors the opportunity to explore an issue in greater dept…Length not stated
- research papersIn addition to research papers and book reviews, The New Bioethics has an Essay section which allows authors the opportunity to explore an issue in greater dept…Length not stated
Policy excerpts from the journal's websitePublication ethics, Open access, Peer review
- Publication ethics
Adheres to publishing ethics standards; Taylor & Francis is a member of COPE and uses CrossCheck. Model summary
The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of Committee of Publications Ethics (COPE) and utilises CrossCheck for all Journals.
Source ↗Publisher website ·- Open access Open access
The New Bioethics is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and reade…
Source ↗Publisher website ·- Peer review
Double-anonymized peer review with a minimum of two reviews per paper. Model summary
The Journal operates a double-anonymized peer review system, with a minimum of two reviews per paper.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 2050-2877
- Electronic ISSN
- 2050-2885
- Latest issue on the website
- Volume 32, Issue 3 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body
What CAS zone is New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body in?
In the 2025 upgraded edition of the CAS Journal Ranking, New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body is in Zone 3 of Philosophy, and in Zone 4 of the minor category Ethics / Medical Ethics / Social Sciences, Biomedical. In the 2026 Xinrui edition it is in Zone 2 of Philosophy. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body?
The journal's website gives an impact factor of 0.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.6, h-index 26.
How long does peer review take at New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body?
The publisher reports about 330 days (first decision after review); the journal's website gives an acceptance rate of 50%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body based?
Of the 6 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (3), Belgium (1) and Denmark (1). Counted from the institutions listed on the board page; for reference only.
Which databases index New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body?
According to LetPub and DOAJ records, New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body is indexed in ESCI and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body open access, and what is the APC?
New Bioethics-A Multidisciplinary Journal of Biotechnology and the Body is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .